Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Short Interest Down 81.1% in December

Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) saw a large drop in short interest in December. As of December 31st, there was short interest totaling 7,789 shares, a drop of 81.1% from the December 15th total of 41,149 shares. Currently, 0.3% of the shares of the stock are short sold. Based on an average daily volume of 26,334 shares, the short-interest ratio is currently 0.3 days. Based on an average daily volume of 26,334 shares, the short-interest ratio is currently 0.3 days. Currently, 0.3% of the shares of the stock are short sold.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Atria Investments Inc purchased a new stake in shares of Invesco Nasdaq Biotechnology ETF in the second quarter valued at about $211,000. Raymond James Financial Inc. purchased a new stake in shares of Invesco Nasdaq Biotechnology ETF in the 2nd quarter valued at approximately $149,000. IHT Wealth Management LLC purchased a new stake in shares of Invesco Nasdaq Biotechnology ETF in the 2nd quarter valued at approximately $211,000. Osaic Holdings Inc. increased its holdings in shares of Invesco Nasdaq Biotechnology ETF by 28.4% during the 2nd quarter. Osaic Holdings Inc. now owns 4,757 shares of the company’s stock worth $101,000 after buying an additional 1,052 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. raised its position in shares of Invesco Nasdaq Biotechnology ETF by 7.3% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 215,722 shares of the company’s stock valued at $5,245,000 after buying an additional 14,717 shares during the period.

Invesco Nasdaq Biotechnology ETF Stock Performance

Shares of NASDAQ IBBQ traded up $0.19 during mid-day trading on Wednesday, reaching $28.93. The company’s stock had a trading volume of 25,091 shares, compared to its average volume of 89,114. The stock has a 50-day moving average of $28.29 and a two-hundred day moving average of $25.34. The stock has a market capitalization of $68.56 million, a P/E ratio of 17.03 and a beta of 0.67. Invesco Nasdaq Biotechnology ETF has a 1-year low of $17.84 and a 1-year high of $29.92.

Invesco Nasdaq Biotechnology ETF Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, December 26th. Investors of record on Monday, December 22nd were issued a $0.0906 dividend. This represents a $0.36 annualized dividend and a dividend yield of 1.3%. The ex-dividend date of this dividend was Monday, December 22nd.

Invesco Nasdaq Biotechnology ETF Company Profile

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.